Insider trades
John W. Kozarich, Director of Ligand Pharmaceuticals LGND, has filed 0 purchases and 51 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/05.
John W. Kozarich
Director
- Company
- Ligand Pharmaceuticals LGND
- First filing
- 23/05/10
- Trades
- 69 trades
- Buys / sales
- 0 / 51
- 12-month net buying
- −$1.2M
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
LGND | Open-market sale10b5-1 plan | 05/01–05/13 | 05/14 | 2,501 sh7 trades | $225.14avg. | $563,080.81 | −5.6% |
LGND | Open-market sale10b5-1 plan | 04/01 | 04/02 | 467 sh5 trades | $202.22avg. | $94,438.87 | −1.1% |
LGND | Open-market sale10b5-1 plan | 03/02 | 03/04 | 467 sh6 trades | $200.50avg. | $93,632.63 | −1.1% |
LGND | Open-market sale10b5-1 plan | 02/02 | 02/04 | 467 sh5 trades | $195.91avg. | $91,488.97 | −1.1% |
LGND | Open-market sale10b5-1 plan | 01/02 | 01/06 | 467 sh5 trades | $189.58avg. | $88,532.05 | −1.1% |
LGND | Open-market sale10b5-1 plan | 25/12/01 | 25/12/03 | 467 sh7 trades | $195.84avg. | $91,458.06 | −1.0% |
LGND | Open-market sale10b5-1 plan | 25/11/03 | 25/11/05 | 467 sh4 trades | $191.05avg. | $89,219.75 | −1.0% |
LGND | Open-market sale10b5-1 plan | 25/10/01 | 25/10/03 | 467 sh4 trades | $179.45avg. | $83,800.87 | −1.0% |
LGND | Open-market sale10b5-1 plan | 25/09/02 | 25/09/04 | 467 sh3 trades | $162.26avg. | $75,774.22 | −1.0% |
| Open-market sale10b5-1 plan | 25/08/01 | 25/08/05 | 467 sh | $131.88 | $61,587.96 | −1.0% | |
| Open-market sale10b5-1 plan | 25/07/10 | 25/07/11 | 934 sh | $125.00 | $116,750 | −2.0% | |
| Open-market sale | 23/05/16 | 23/05/18 | 4,444 sh | $77.20 | $343,076.8 | −10.4% | |
LGND | Open-market sale | 23/05/08 | 23/05/10 | 6,408 sh2 trades | $76.56avg. | $490,623.59 | −13.2% |